These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19484390)

  • 21. Homocysteine lowering and cardiovascular disease risk: lost in translation.
    Marcus J; Sarnak MJ; Menon V
    Can J Cardiol; 2007 Jul; 23(9):707-10. PubMed ID: 17622392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The controversial role of B-vitamins in cardiovascular risk: An update.
    Ntaios G; Savopoulos C; Grekas D; Hatzitolios A
    Arch Cardiovasc Dis; 2009 Dec; 102(12):847-54. PubMed ID: 19963194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Homocysteine, folic acid, group B vitamins and cardiovascular risk].
    Blacher J; Czernichow S; Horrellou MH; Conad J; David P; Chadefaux-Vekemans B; Ankria A; Galan P; Hercberg S; Ducimetière P
    Arch Mal Coeur Vaiss; 2005 Feb; 98(2):145-52. PubMed ID: 15787307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults.
    Carlsson CM
    Drugs Aging; 2006; 23(6):491-502. PubMed ID: 16872232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine and cardiovascular disease: current evidence and future prospects.
    Mangoni AA; Jackson SH
    Am J Med; 2002 May; 112(7):556-65. PubMed ID: 12015248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homocysteine and risk of cardiovascular disease.
    Andreotti F; Burzotta F; Manzoli A; Robinson K
    J Thromb Thrombolysis; 2000 Jan; 9(1):13-21. PubMed ID: 10590184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine-lowering interventions for preventing cardiovascular events.
    Martí-Carvajal AJ; Solà I; Lathyris D; Karakitsiou DE; Simancas-Racines D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD006612. PubMed ID: 23440809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.
    Mallamaci F; Zoccali C; Tripepi G; Fermo I; Benedetto FA; Cataliotti A; Bellanuova I; Malatino LS; Soldarini A;
    Kidney Int; 2002 Feb; 61(2):609-14. PubMed ID: 11849403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring the homocysteine level.
    Scott PM
    JAAPA; 2005 Sep; 18(9):57. PubMed ID: 16184873
    [No Abstract]   [Full Text] [Related]  

  • 30. Homocysteine-lowering interventions for preventing cardiovascular events.
    Martí-Carvajal AJ; Solà I; Lathyris D
    Cochrane Database Syst Rev; 2015 Jan; 1():CD006612. PubMed ID: 25590290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?
    Debreceni B; Debreceni L
    Cardiovasc Ther; 2012 Aug; 30(4):227-33. PubMed ID: 21884001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperhomocysteinemia and hyperlipoproteinemia (a) in obese South Indian men: an indication for increased cardiovascular risk.
    Ikkruthi S; Rajappa M; Nandeesha H; Satheesh S; Sundar I; Ananthanarayanan PH; Harichandrakumar KT
    Acta Physiol Hung; 2014 Mar; 101(1):13-20. PubMed ID: 24311227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.
    Sharma M; Tiwari M; Tiwari RK
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):287-96. PubMed ID: 26036286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homocysteine-lowering trials for prevention of heart disease and stroke.
    Clarke R
    Semin Vasc Med; 2005 May; 5(2):215-22. PubMed ID: 16047274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Homocysteine and cardiovascular risk].
    Mazza A; Bossone E; Mazza F; Distante A
    Monaldi Arch Chest Dis; 2004 Mar; 62(1):29-33. PubMed ID: 15211734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperhomocysteinemia in patients with cardiovascular disease].
    Baszczuk A; Kopczyński Z
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():579-89. PubMed ID: 24864108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homocysteine and cardiovascular disease: a review of the evidence.
    Wierzbicki AS
    Diab Vasc Dis Res; 2007 Jun; 4(2):143-50. PubMed ID: 17654449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.